Overview

  • Product nameNNC 05-2090
  • Description
    GABA uptake inhibitor
  • Biological descriptionGABA uptake inhibitor, selective for the BGT-1 transporter (Ki values are 1.4 (BGT-1), 19 (GAT-1), 41 (GAT-2) and 15 μM (GAT-3)). Also active at α1- and D2-receptors (IC50 values are 266 and 1632 nM, respectively). Anticonvulsant in vivo.
  • Purity> 99%

Properties

    References for NNC 05-2090 (ab120317)

    This product has been referenced in:
    • Thomsen C  et al. 1-(3-(9H-carbazol-9-yl)-1-propyl)-4-(2-methoxyphenyl)-4-piperidinol, a novel subtype selective inhibitor of the mouse type II GABA-transporter. Br J Pharmacol 120:983-5 (1997). Read more (PubMed: 9134205) »
    • Dalby NO  et al. Anticonvulsant properties of two GABA uptake inhibitors NNC 05-2045 and NNC 05-2090, not acting preferentially on GAT-1. Epilepsy Res 28:51-61 (1997). Read more (PubMed: 9255599) »

    See 0 Publications for this product

    Product Wall

    There are currently no Abreviews or Questions for ab120317.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"